
Psychosomatics 44:244-248, June 2003
© 2003 The Academy of Psychosomatic Medicine
Somatic Symptoms for Diagnosing Major Depression in Cancer Patients
Tatsuo Akechi, M.D., Ph.D.,
Tomohito Nakano, M.D.,
Nobuya Akizuki, M.D.,
Masako Okamura, M.D.,
Keiko Sakuma, M.D.,
Tatsuro Nakanishi, M.D.,
Eisho Yoshikawa, M.D., and
Yosuke Uchitomi, M.D., Ph.D.
Received May 14, 2002; revision received Sept. 20, 2002; accepted Oct. 18, 2002. From the Psycho-Oncology Division, National Cancer Center Research Institute East; the Psychiatry Divisions of the National Cancer Center Hospital (Tsukiji, Japan) and the National Cancer Center Hospital East (Kashiwa, Japan); and the Department of Psychiatry, Kashiwa Hospital, Jikei Medical University, Kashiwa, Japan. Address reprint requests to Dr. Uchitomi, Psycho-Oncology Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; yuchitom{at}east.ncc.go.jp (e-mail).
Diagnosing depression in cancer patients has been challenging because the diagnostic criteria include somatic symptoms frequently attributed to the cancer itself or its treatment. However, few studies have explored how to appropriately deal with individual somatic symptoms. The authors used data from 220 cancer patients with major depression to examine the intercorrelations among the DSM-IV somatic and nonsomatic symptom criteria as well as whether the presence of an individual somatic symptom could discriminate the severity of major depression. Appetite changes and a diminished ability to think were positively associated with anhedonia. Sleep disturbance and fatigue were not significantly associated with nonsomatic symptoms. These associations were consistent after adjusting for physical functioning and pain. Only patients with appetite changes showed a higher severity of depression. These results suggest that individual somatic symptoms differ in nature and that appetite-related symptoms and a diminished ability to think may be useful for diagnosing depression in cancer patients, whereas sleep disturbances and fatigue may not be as useful.
This article has been cited by other articles:

|
 |

|
 |
 
S. F. Garcia, D. Cella, S. B. Clauser, K. E. Flynn, T. Lad, J.-S. Lai, B. B. Reeve, A. Wilder Smith, A. A. Stone, and K. Weinfurt
Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative
J. Clin. Oncol.,
November 10, 2007;
25(32):
5106 - 5112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.P. van Wilgen, P.U. Dijkstra, R.E. Stewart, A.V. Ranchor, and J.L.N. Roodenburg
Measuring Somatic Symptoms With the CES-D to Assess Depression in Cancer Patients After Treatment: Comparison Among Patients With Oral/Oropharyngeal, Gynecological, Colorectal, and Breast Cancer
Psychosomatics,
December 1, 2006;
47(6):
465 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Grassi, E. Rossi, S. Sabato, G. Cruciani, and M. Zambelli
Diagnostic Criteria for Psychosomatic Research and Psychosocial Variables in Breast Cancer Patients
Psychosomatics,
December 1, 2004;
45(6):
483 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2003
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|